De Lorenzo MS - Search Results

1

The copper-chelating agent, trientine, suppresses tumor development and angiogenesis in the murine hepatocellular carcinoma cells.

Yoshii J, Yoshiji H, Kuriyama S, Ikenaka Y, Noguchi R, Okuda H, Tsujinoue H, Nakatani T, Kishida H, Nakae D, Gomez DE, De Lorenzo MS, Tejera AM, Fukui H. Yoshii J, et al. Among authors: de lorenzo ms. Int J Cancer. 2001 Dec 15;94(6):768-73. doi: 10.1002/ijc.1537. Int J Cancer. 2001. PMID: 11745476

2

Fibrin formation induced by tumor procoagulants enhances urokinase activity produced by mammary carcinoma cells.

Alonso DF, De Lorenzo MS, Tejera AM, Gomez DE. Alonso DF, et al. Among authors: de lorenzo ms. Oncol Rep. 1998 Jan-Feb;5(1):209-12. Oncol Rep. 1998. PMID: 9458324

3

Altered tumor angiogenesis and metastasis of B16 melanoma in transgenic mice overexpressing tissue inhibitor of metalloproteinases-1.

de Lorenzo MS, Ripoll GV, Yoshiji H, Yamazaki M, Thorgeirsson UP, Alonso DF, Gomez DE. de Lorenzo MS, et al. In Vivo. 2003 Jan-Feb;17(1):45-50. In Vivo. 2003. PMID: 12655789

4

Reduction of mouse mammary tumor formation and metastasis by lovastatin, an inhibitor of the mevalonate pathway of cholesterol synthesis.

Alonso DF, Farina HG, Skilton G, Gabri MR, De Lorenzo MS, Gomez DE. Alonso DF, et al. Among authors: de lorenzo ms. Breast Cancer Res Treat. 1998 Jul;50(1):83-93. doi: 10.1023/a:1006058409974. Breast Cancer Res Treat. 1998. PMID: 9802623

5

Histopathological findings in a highly invasive mouse mammary carcinoma transfected with human tissue inhibitor of metalloproteinases-1.

Alonso DF, Skilton G, De Lorenzo MS, Scursoni AM, Yoshiji H, Gomez DE. Alonso DF, et al. Among authors: de lorenzo ms. Oncol Rep. 1998 Sep-Oct;5(5):1083-7. doi: 10.3892/or.5.5.1083. Oncol Rep. 1998. PMID: 9683813

6

In vitro activity of a Solanum tuberosum extract against mammary carcinoma cells.

De Lorenzo MS, Lorenzano Menna PL, Alonso DF, Gomez DE. De Lorenzo MS, et al. Planta Med. 2001 Mar;67(2):164-6. doi: 10.1055/s-2001-11502. Planta Med. 2001. PMID: 11301867

7

Nafoxidine modulates the expression of matrix-metalloproteinase-2 (MMP-2) and tissue inhibitor of metalloproteinases-1 (TIMP-1) in endothelial cells.

De Lorenzo MS, Alonso DF, Gomez DE. De Lorenzo MS, et al. Anticancer Res. 2000 Jan-Feb;20(1A):395-400. Anticancer Res. 2000. PMID: 10769686

8

Modulation of growth and urokinase secretion by vasopressin and closely related nonapeptides in metastatic mouse mammary tumor cells.

Alonso D, Skilton G, Farina H, Delorenzo M, Gomez D. Alonso D, et al. Int J Oncol. 1997 Feb;10(2):375-9. doi: 10.3892/ijo.10.2.375. Int J Oncol. 1997. PMID: 21533387

9

Role of protein kinase C-dependent signaling pathways in the antiangiogenic properties of nafoxidine.

De Lorenzo MS, Farina HG, Alonso DF, Gomez DE. De Lorenzo MS, et al. Anticancer Res. 2004 May-Jun;24(3a):1737-43. Anticancer Res. 2004. PMID: 15274349 Free article.

10

Expression of metalloproteinases (MMP-1, MMP-2, and MMP-9) and their inhibitors (TIMP-1 and TIMP-2) in schistosomal portal fibrosis.

Gomez DE, De Lorenzo MS, Alonso DF, Andrade ZA. Gomez DE, et al. Among authors: de lorenzo ms. Am J Trop Med Hyg. 1999 Jul;61(1):9-13. doi: 10.4269/ajtmh.1999.61.9. Am J Trop Med Hyg. 1999. PMID: 10432047

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters